SCHEMBL30735835

SCHEMBL30735835

Clc1cnc(C2CCNCC2)c2ccccc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC18A3 Q16572 1/20 0.42
SIGMAR1 Q99720 1/20 0.42
HTR1A P08908 2/20 0.41
SLC6A2 P23975 2/20 0.41
SLC6A4 P31645 2/20 0.41
SLC6A3 Q01959 2/20 0.41
HTR2C P28335 5/20 0.41
ADRB2 P07550 1/20 0.41
KDM4E B2RXH2 1/20 0.40
ALDH1A1 P00352 1/20 0.40
POLB P06746 1/20 0.40
HTR2A P28223 1/20 0.38
KCNH2 Q12809 1/20 0.38
CHRNB2 P17787 1/20 0.38
CHRNA4 P43681 1/20 0.38
CDK9 P50750 3/20 0.37
CDK7 P50613 1/20 0.37
PLAU P00749 1/20 0.37
CCNT1 O60563 2/20 0.37
JUND P17535 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19297028 1.00 SLC18A3 (0.42) SLC18A3SIGMAR1HTR1ASLC6A2SLC6A4
SCHEMBL31364014 0.83 TDP1 (0.43) KDM4EALDH1A1POLBPLAUTLR7
SCHEMBL19297228 0.81 SLC18A3 (0.42) SLC18A3SIGMAR1HTR1ASLC6A2SLC6A4
SCHEMBL30735575 0.81 SLC18A3 (0.42) SLC18A3SIGMAR1HTR1ASLC6A2SLC6A4
Hydrochloric Acid SCHEMBL29862710 0.79 HTR2C (0.42) SLC18A3SIGMAR1HTR1ASLC6A2SLC6A4
SCHEMBL30735594 0.77 HTR2C (0.53) SLC18A3SIGMAR1HTR1ASLC6A2SLC6A4
SCHEMBL19297033 0.77 HTR2C (0.53) SLC18A3SIGMAR1HTR1ASLC6A2SLC6A4
SCHEMBL4962813 0.72 MEN1 (0.43) SLC18A3SIGMAR1HTR2CADRB2HTR2A
SCHEMBL6275687 0.72 HTR2C (0.50) SLC18A3SIGMAR1HTR1ASLC6A2SLC6A4
SCHEMBL30735510 0.72 MEN1 (0.43) SLC18A3SIGMAR1HTR2CADRB2HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11891369-B2 Compounds for binding proprotein convertase subtilisin/kexin type 9 SRX CARDIO, LLC (US) 2024-02-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11891369-B2 Compounds for binding proprotein convertase subtilisin/kexin type 9 PCSK9, PCSK6, PCSK7 SLC18A3 4418/4885SIGMAR1 4853/4885HTR1A 3211/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.